Stock DC8A DURECT CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. DURECT Corporation Deutsche Boerse AG

Equities

DC8A

US2666055007

Real-time Estimate Tradegate
Other stock markets
 02:45:17 2024-07-17 pm EDT 		5-day change 1st Jan Change
1.32 EUR +10.00% Intraday chart for DURECT Corporation +1.68% +130.48%
May. 21 DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis CI
May. 21 Sector Update: Health Care Stocks Edge Higher Tuesday Afternoon MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says
MT
JonesTrading Downgrades Durect to Hold From Buy
MT
HC Wainwright Downgrades Durect to Neutral From Buy
MT
Cantor Fitzgerald Adjusts Price Target on Durect to $41 From $44, Keeps Overweight Rating
MT
HC Wainwright Adjusts Price Target on Durect to $27 From $32, Maintains Buy Rating
MT
JonesTrading Initiates Durect at Buy With $37 Price Target
MT
HC Wainwright Trims Price Target on Durect to $32 From $35, Maintains Buy Rating
MT
Oppenheimer Adjusts Price Target on Durect to $32 From $6 on Reverse Stock Split, Market Conditions, Maintains Outperform Rating
MT
DURECT : Chardan Suspends Coverage on Durect at Buy Rating With $8 Price Target
MT
DURECT : Chardan Adjusts Price Target on Durect to $8 From $7, Maintains Buy Rating
MT
Berenberg NASH Day
FA
DURECT Corporation : to Participate in the Berenberg NASH Day
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DRRX Stock
  4. DC8A Stock
  5. News DURECT Corporation
  6. Analyst Reco.